Details for New Drug Application (NDA): 077101
✉ Email this page to a colleague
The generic ingredient in QUASENSE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 077101
Tradename: | QUASENSE |
Applicant: | Watson Labs |
Ingredient: | ethinyl estradiol; levonorgestrel |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.03MG;0.15MG | ||||
Approval Date: | Sep 6, 2006 | TE: | AB | RLD: | No |
Complete Access Available with Subscription